Brief: Emmaus Life Sciences Reiterates Financial Benefits From Recent Merger

Emmaus Life Sciences

08/08/2019 20:57

Aug 8 (Reuters) - Emmaus Life Sciences Inc  EMMA.O :
    * EMMAUS LIFE SCIENCES REITERATES FINANCIAL BENEFITS FROM
RECENT
MERGER
    * EMMAUS LIFE SCIENCES INC - WILL REPORT RESULTS FOR Q2 AND
SIX
MONTHS ENDED JUNE 30, 2019 NEXT WEEK
    * EMMAUS LIFE SCIENCES - REQUESTED HEARING TO APPEAL
PREVIOUSLY
ANNOUNCED DETERMINATION OF NASDAQ STOCK MARKET TO DELIST CO'S
STOCK FROM NASDAQ CAPITAL MARKET
    * EMMAUS LIFE SCIENCES INC - CO'S STOCK WILL CONTINUE TO
TRADE ON
NASDAQ CAPITAL MARKET UNTIL HEARING, WHICH IS SCHEDULED FOR
SEPTEMBER 5, 2019

Source text for Eikon:  urn:newsml:reuters.com:*:nPn6rGX7ra
Further company coverage:  EMMA.O 

 ((Reuters.Briefs@thomsonreuters.com;))